NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Cambridge, United States Read more
Dr John TALLARICO
Global Head, Chemical Biology and Therapeutics Department, Novartis Institutes for Biomedical Research since 2021. John has been with Novatis in progressive roles since 2004 when he joined the Global Discovery Chemistry department to help found the Chemical Genetics group there.
Previously, Dr. Tallarico served as Head of Chemical Technology, an Institute Fellow at the Harvard Institute of Chemistry and Cell Biology (ICCB) and an instructor in the Department of Cell Biology. The Harvard ICCB is a joint initiative of Harvard Medical School and Harvard University where research was focused on developing the nascent field of chemical genetics.
Dr. Tallarico’s post-doctoral studies were performed at Harvard Medical School and Harvard University as a Fellow of the Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation. It was at this time, that Dr. Tallarico began his work in the field of chemical genetics where he worked with a team of researchers to build the chemical technology platform central to the ICCB discovery efforts. His laboratory was specifically interested in bringing the power of chemistry to help understand biological systems.
Dr. Tallarico received his B.A in Chemistry at Miami University, Oxford, Ohio in 1993, and his Ph.D. in Organic Chemistry at Boston College in 1999.
Confirmed Invited Speakers
Dr Marcus BANTSCHEFF
CELLZOME/GSK, Heidelberg, Germany
Prof. Martin BLACKLEDGE
INSTITUT DE BIOLOGIE STRUCTURALE (IBS), Grenoble, France
Dr Kimberly BONGER
RADBOUD UNIVERSITY, Nijmegen, The Netherlands
Dr Samuele CAZZAMALLI
PHILOCHEM AG, Otelfingen, Switzerland
Dr Alberto FERNÁNDEZ-TEJADA
CIC BIOGUNE, Derio (Bizkaia), Spain
Mrs Dorothea FIEDLER
LEIBNIZ-FORSCHUNGSINSTITUT FÜR MOLEKULARE PHARMAKOLOGIE (FMP), Berlin, Germany
Prof. Beat FIERZ
ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE, Lausanne, Switzerland
Dr Rachel GRIMLEY
CANCER RESEARCH HORIZONS - THERAPEUTIC INNOVATION, Glasgow, United Kingdom
Dr Stephan HACKER
LEIDEN UNIVERSITY, Leiden, The Netherlands
Prof. Dorothee KERN
BRANDEIS UNIVERSITY, Waltham, United States
Dr Luca LARAIA
TECHNICAL UNIVERSITY OF DENMARK, Kgs. Lyngby, Denmark Read more
Dr Luca LARAIA
Biosketch: Luca studied chemistry at Imperial College London before obtaining a PhD in chemical biology from the University of Cambridge in 2014. He moved to the Max Planck Institute of molecular physiology as an Alexander von Humboldt post-doctoral researcher before taking up an assistant professorship at the Technical University of Denmark. As an associate professor in chemical biology, he now leads a research group focused on developing chemical tools to study sterol-mediated processes as well as new methods in natural product-inspired compound library synthesis.
Prof. Alessandra MAGISTRATO
CNR-IOM, Trieste, Italy
Prof. Manuel MELO
UNIVERSITY NOVA DE LISBOA, Oeiras, Portugal
Prof. Tom MUIR
PRINCETON UNIVERSITY, Princeton, United States Read more
Prof. Tom MUIR
Tom W. Muir received his B.Sc in chemistry from the University of Edinburgh in 1989 and his Ph.D. in chemistry from the same institute in 1993 under the direction of Professor Robert Ramage. After postdoc studies with Stephen B.H. Kent at The Scripps Research Institute, he joined the faculty of The Rockefeller University in 1996, where he was, until 2011, the Richard E. Salomon Family Professor and Director of the Pels Center of Chemistry, Biochemistry and Structural Biology. In 2011, Dr. Muir joined the faculty of Princeton University as the Van Zandt Williams Jr. Class of ’65 Professor of Chemistry. He served as Chair of the Chemistry Department until 2020. He has published over 250 scientific articles in the area of chemical biology and is best known for developing methods for the preparation of proteins containing unnatural amino acids, posttranslational modifications and spectroscopic probes. These approaches are now widely employed in academia and industry. His current interests lie in the area of epigenetics, where he tries to illuminate how chemical changes to chromatin drive different cellular phenotypes.
Prof. Andras PERCZEL
EÖTVÖS LORÁND UNIVERSITY, Budapest, Hungary
Dr Mikhail SAVITSKY
EUROPEAN MOLECULAR BIOLOGY LABORATORY, Heidelberg, Germany
Dr Meha SINGH
ASTRAZENECA, Waltham, United States
Prof. Alice TING
STANFORD UNIVERSITY, Stanford, United States Read more
Prof. Alice TING
Alice Ting is a Professor of Genetics, Biology, and by courtesy, Chemistry at Stanford University. Alice’s work straddles the interface of chemistry and biology and the molecular technologies she has developed, including enzyme-catalyzed proximity labeling, have been widely adopted in cell biology and neuroscience to probe organelle proteomes and protein interaction networks. She has received the NIH Pioneer Award, the Arthur Cope Scholar Award, and the McKnight Technological Innovations in Neuroscience Award. Alice has been a Chan Zuckerberg Biohub investigator since 2017. Prior to Stanford, Alice was Professor of Chemistry at MIT and she received her training at Harvard with EJ Corey, UC Berkeley with Peter Schultz, and UCSD with Roger Tsien.
Prof. Matthew G. VANDER HEIDEN
MIT, Cambridge, United States
Prof. Marc VENDRELL
UNIVERSITY OF EDINBURGH, Edinburgh, United Kingdom